13F

Stock

Arcadia Biosciences, Inc.

RKDA · held by 16 managers

Reported value

$482.1K

Holders

16

+4 new · −3 exited

Holders’ est. mark

−$15K

Price effect on 10 books still in the name

Largest holder

$220K

ARMISTICE CAPITAL, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ARMISTICE CAPITAL, LLC159.4K$220KNew
SABBY MANAGEMENT, LLC114.6K$158.1KNew
GEODE CAPITAL MANAGEMENT, LLC31.7K$43.8K−$6.39KAdded$22.7K
SUSQUEHANNA INTERNATIONAL GROUP, LLP12.6K$17.4KNew
State Street12.1K$16.8K−$7.29KCut−$7.29K
VANGUARD CAPITAL MANAGEMENT LLC9.64K$13.3KHeld
VANGUARD FIDUCIARY TRUST CO4.39K$6.06KHeld
Tower Research Capital LLC (TRC)3.94K$5.44K−$885Added$2.52K
UBS Group AG807$1.11K−$339Cut−$5
SBI Securities Co., Ltd.120$166−$72Cut−$72
GROUP ONE TRADING LLC18$25−$11Cut−$11
ASSETMARK, INC5$7−$3Cut−$3
SOUTHERN MICHIGAN BANK & TRUST2$3Held
MORGAN STANLEY2$3−$1Cut−$1
CITIGROUP INC1$1−$1Cut−$1
HARBOUR INVESTMENTS, INC.1$1−$1Cut−$1

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.